Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · July 18, 2019

Rituximab as an Adjuvant Therapy for Pemphigus

International Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Dermatology
Rituximab as an Adjuvant Therapy for Pemphigus: Experience in 61 Patients From a Single Center With Long-Term Follow-Up
Int. J. Dermatol 2019 Jun 30;[EPub Ahead of Print], VK Sharma, V Gupta, N Bhari, V Singh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading